BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 443066)

  • 1. Fasting and prolonged exercise increase vasoactive intestinal polypeptide (VIP) in plasma.
    Galbo H; Hilsted J; Fahrenkrug J; Schaffalitzky De Muckadell OB
    Acta Physiol Scand; 1979 Mar; 105(3):374-7. PubMed ID: 443066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic hormonal changes during exercise.
    Hilsted J; Galbo H; Sonne B; Schwartz T; Fahrenkrug J; de Muckadell OB; Lauritsen KB; Tronier B
    Am J Physiol; 1980 Sep; 239(3):G136-40. PubMed ID: 6108073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of vasoactive intestinal polypeptide, secretin, and human pancreatic polypeptide to glucose during fasting.
    Oktedalen O; Opstad PK; Jorde R; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1984 Jan; 19(1):59-64. PubMed ID: 6710078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal hyperchlorhydria and its relation to the plasma concentrations of secretin, vasoactive intestinal polypeptide (VIP) and gastrin during prolonged strain.
    Oektedalen O; Opstad PK; Schaffalitzky de Muckadell OB; Fausa O; Flaten O
    Regul Pept; 1983 Feb; 5(3):235-44. PubMed ID: 6844664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a test meal on plasma vasoactive intestinal polypeptide (VIP), gastric inhibitory polypeptide (GIP), and secretin in man.
    Burhol PG; Waldum HL; Jorde R; Lygren I
    Scand J Gastroenterol; 1979; 14(8):939-43. PubMed ID: 531513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal regulatory peptides during oxytocin infusion in post-term pregnancies.
    Holst N; Jenssen TG; Burhol PG; Jorde R
    Acta Physiol Scand; 1988 Jan; 132(1):23-7. PubMed ID: 2906209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma gastrointestinal regulatory peptides in exercise-induced asthma.
    Hvidsten D; Jenssen TG; Bolle R; Burhol PG
    Eur J Respir Dis; 1986 May; 68(5):326-31. PubMed ID: 2874049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gastroenteroinsular response to glucose ingestion during postexercise recovery.
    O'Connor AM; Pola S; Ward BM; Fillmore D; Buchanan KD; Kirwan JP
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1155-61. PubMed ID: 16403776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasma concentrations of secretin and vasoactive intestinal polypeptide (VIP) after long-term, strenuous exercise.
    Oktedalen O; Opstad PK; Schaffalitzky de Muckadell OB
    Eur J Appl Physiol Occup Physiol; 1983; 52(1):5-8. PubMed ID: 6686128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentration of vasoactive intestinal polypeptide during prolonged physical exercise, calorie supply deficiency, and sleep deprivation.
    Oktedalen O; Opstad PK; Fahrenkrug J; Fonnum F
    Scand J Gastroenterol; 1983 Nov; 18(8):1057-62. PubMed ID: 6673075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of fasting and postprandial plasma VIP in man.
    Mitchell SJ; Bloom SR
    Gut; 1978 Nov; 19(11):1043-8. PubMed ID: 730071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide (VIP) in children with neural crest tumours.
    Scheibel E; Rechnitzer C; Fahrenkrug J; Hertz H
    Acta Paediatr Scand; 1982 Sep; 71(5):721-5. PubMed ID: 6295059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in humans.
    Woie L; Kaada B; Opstad PK
    Gen Pharmacol; 1986; 17(3):321-6. PubMed ID: 3721187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1981 Feb; 108(2):395-8. PubMed ID: 7449730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The plasma vasoactive intestinal peptide (VIP) response to exercise is increased after prolonged strain, sleep and energy deficiency and extinguished by glucose infusion.
    Opstad PK
    Peptides; 1987; 8(1):175-8. PubMed ID: 3575149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of vasoactive intestinal polypeptide in plasma.
    Burhol PG; Lygren I; Waldum HL
    Scand J Gastroenterol; 1978; 13(7):807-13. PubMed ID: 725503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jul; 111(1):338-40. PubMed ID: 7084118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide in obesity.
    Tomkin GH; Ardill J; Lafferty H; Darragh A
    Int J Obes; 1983; 7(2):153-60. PubMed ID: 6345422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.